Literature DB >> 23159234

Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications.

Hui Xue1, Joachim H Ix, Weiling Wang, Steven M Brunelli, Michael Lazarus, Raymond Hakim, Eduardo Lacson.   

Abstract

BACKGROUND: Hemodialysis (HD) access is considered a critical and actionable determinant of morbidity, with a growing literature suggesting that initial HD access type is an important marker of long-term outcomes. Accordingly, we examined HD access during the incident dialysis period, focusing on infection risk and successful fistula creation during the first dialysis year. STUDY
DESIGN: Longitudinal cohort. SETTING & PARTICIPANTS: All US adults admitted to Fresenius Medical Care North America facilities within 15 days of first maintenance dialysis session between January 1 and December 31, 2007. PREDICTOR: Vascular access type at HD therapy initiation. OUTCOMES: Vascular access type at 90 days and at the end of the first year on HD therapy, bloodstream infection within the first year by access type, and catheter complication rate.
RESULTS: Of 25,003 incident dialysis patients studied, 19,622 (78.5%) initiated dialysis with a catheter; 4,151 (16.6%), with a fistula; and 1,230 (4.9%), with a graft. At 90 days, 14,105 (69.7%) had a catheter, 4,432 (21.9%) had a fistula, and 1,705 (8.4%) had a graft. Functioning fistulas and grafts at dialysis therapy initiation had first-year failure rates of 10% and 15%, respectively. Grafts were seldom replaced by fistulas (3%), whereas 7,064 (47.6%) of all patients who initiated with a catheter alone still had only a catheter at 1 year. Overall, 3,327 (13.3%) patients had at least one positive blood culture during follow-up, with the risk being similar between the fistula and graft groups, but approximately 3-fold higher in patients with a catheter (P<0.001 for either comparison). Nearly 1 in 3 catheters (32.5%) will require tissue plasminogen activator use by a median of 41 days, with 59% requiring more than one tissue plasminogen activator administration. LIMITATIONS: Potential underestimation of bacteremia because follow-up blood culture results did not include samples sent to local laboratories.
CONCLUSIONS: In a large and representative population of incident US dialysis patients, catheter use remains very high during the first year of HD care and is associated with high mechanical complication and bloodstream infection rates.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23159234      PMCID: PMC3532948          DOI: 10.1053/j.ajkd.2012.09.006

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  31 in total

Review 1.  That catheter is going to cost you!

Authors:  Jeffrey S Berns
Journal:  Semin Dial       Date:  2006 Sep-Oct       Impact factor: 3.455

2.  Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study.

Authors:  Areef Ishani; Allan J Collins; Charles A Herzog; Robert N Foley
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

Review 3.  Identification of patients and risk factors in chronic kidney disease--evaluating risk factors and therapeutic strategies.

Authors:  A Levin
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

4.  Type of vascular access and mortality in U.S. hemodialysis patients.

Authors:  R K Dhingra; E W Young; T E Hulbert-Shearon; S F Leavey; F K Port
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

5.  Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.

Authors:  Brad C Astor; Joseph A Eustace; Neil R Powe; Michael J Klag; Nancy E Fink; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2005-03-23       Impact factor: 10.121

6.  Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes.

Authors:  Timmy Lee; Jill Barker; Michael Allon
Journal:  Am J Kidney Dis       Date:  2005-09       Impact factor: 8.860

Review 7.  Dialysis catheter-related bacteremia: treatment and prophylaxis.

Authors:  Michael Allon
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

8.  Septicemia in dialysis patients: incidence, risk factors, and prognosis.

Authors:  N R Powe; B Jaar; S L Furth; J Hermann; W Briggs
Journal:  Kidney Int       Date:  1999-03       Impact factor: 10.612

9.  Role of vascular access as a risk factor for infections in hemodialysis.

Authors:  S Gulati; K M Sahu; S Avula; R K Sharma; A Ayyagiri; C M Pandey
Journal:  Ren Fail       Date:  2003-11       Impact factor: 2.606

10.  Effect of change in vascular access on patient mortality in hemodialysis patients.

Authors:  Michael Allon; John Daugirdas; Thomas A Depner; Tom Greene; Daniel Ornt; Steve J Schwab
Journal:  Am J Kidney Dis       Date:  2006-03       Impact factor: 8.860

View more
  32 in total

1.  The upfront risks of vascular access complications.

Authors:  Louise M Moist; Ahmed A Al-Jaishi
Journal:  J Am Soc Nephrol       Date:  2013-08-22       Impact factor: 10.121

2.  Vascular access choice in incident hemodialysis patients: a decision analysis.

Authors:  David A Drew; Charmaine E Lok; Joshua T Cohen; Martin Wagner; Navdeep Tangri; Daniel E Weiner
Journal:  J Am Soc Nephrol       Date:  2014-07-25       Impact factor: 10.121

Review 3.  A practical review of the use of stents for the maintenance of hemodialysis access.

Authors:  Michael Ginsburg; Jonathan M Lorenz; Sean P Zivin; Steven Zangan; Don Martinez
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

4.  Early Mortality Associated with Inpatient versus Outpatient Hemodialysis Initiation in a Large Cohort of US Veterans with Incident End-Stage Renal Disease.

Authors:  Faisal M Arif; Keiichi Sumida; Miklos Z Molnar; Praveen K Potukuchi; Jun Ling Lu; Fatima Hassan; Fridtjof Thomas; Omer A Siddiqui; Geeta G Gyamlani; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Nephron       Date:  2017-04-27       Impact factor: 2.847

5.  Reducing catheter-related infections in hemodialysis patients.

Authors:  Daniel Landry; Gregory Braden
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-26       Impact factor: 8.237

6.  Hospitalization Among Individuals Waitlisted For Kidney Transplant.

Authors:  Kira L Newman; Raymond J Lynch; Andrew B Adams; Rebecca Zhang; Stephen O Pastan; Rachel E Patzer
Journal:  Transplantation       Date:  2017-12       Impact factor: 4.939

Review 7.  Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.

Authors:  Nursel Calik Basaran; Sibel Ascioglu
Journal:  Ther Adv Infect Dis       Date:  2017-10-17

8.  Impact of break-in period on the short-term outcomes of patients started on peritoneal dialysis.

Authors:  Yaorong Liu; Lin Zhang; Aiwu Lin; Zhaohui Ni; Jiaqi Qian; Wei Fang
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

9.  Peripherally Inserted Central Catheters and Hemodialysis Outcomes.

Authors:  Rita L McGill; Robin Ruthazer; Klemens B Meyer; Dana C Miskulin; Daniel E Weiner
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

10.  Health status as a potential mediator of the association between hemodialysis vascular access and mortality.

Authors:  Vanessa Grubbs; Haimanot Wasse; Eric Vittinghoff; Barbara A Grimes; Kirsten L Johansen
Journal:  Nephrol Dial Transplant       Date:  2013-11-13       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.